ARCHIVES

NCI Begins Phase III Trial Of Shark Cartilage In NSCLC.

This article is from The Cancer Letter archive.

Vol. 27 No. 21 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Awards STRAP Grant Of $2 Million To MSKCC

October 22, 2010

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980